Lupus nephritis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(36 intermediate revisions by 6 users not shown)
Line 3: Line 3:
   Name          = Lupus nephritis |
   Name          = Lupus nephritis |
   Image          = dpgn.jpg|
   Image          = dpgn.jpg|
   Caption        = Type IV lupus nephritis: The classic "flea-bitten" appearance of the cortical surface in the diffuse proliferative glomerulonephritides. (Courtesy of Ed Uthman, MD)]]|
   Caption        = <nowiki>Type IV lupus nephritis: The classic "flea-bitten" appearance of the cortical surface in the diffuse proliferative glomerulonephritides. (Courtesy of Ed Uthman, MD)]]</nowiki>|
  DiseasesDB    = |
  ICD10          = {{ICD10|N|08|5|n|00}} |
  ICD9          = {{ICD9|583.81}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = 000481 |
  MeshID        = D008181 |
}}
}}
{{Search infobox}}
{{Lupus nephritis}}


'''For patient information, click [[{{PAGENAME}} (patient information)|here]]'''
'''For patient information, click [[{{PAGENAME}} (patient information)|here]]'''


{{CMG}}; {{AE}} {{CZ}}; [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]; {{RT}}
{{CMG}}; {{AE}}[[User:Okamal|Omer Kamal, M.D.]][mailto:okamal@bidmc.harvard.edu <nowiki>[2]</nowiki>] {{CZ}}; [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]; {{AIDA}}{{RT}}''' '''


==Overview==
{{SK}} Nephritis - lupus; lupus glomerular disease
'''Lupus nephritis''' is an inflammation of the kidney caused by [[systemic lupus erythematosus]] ([[SLE]]), a disease of the [[immune system]].  Apart from the kidneys, SLE can also damage the [[skin]], joints, [[nervous system]] and virtually any organ or system in the body.


==Classification==
== [[Lupus nephritis overview|Overview]] ==
The World Health Organization has divided lupus nephritis into five classes based on the [[biopsy]].
*Class I is histologically normal and does not show any evidence of disease.
*Class II is based on a finding of mesangial lupus nephritis
*Class III is focal proliferative [[nephritis]]
*Class IV is diffuse proliferative nephritis
*Class V is membranous nephritis and is characterized by extreme edema and protein loss.
*Class VI Glomerulosclerosis


==Pathophysiology==
== [[Lupus nephritis historical perspective|Historical Perspective]] ==
Systemic lupus erythematosus (SLE, or lupus) is an [[autoimmune]] disease.  This means there is a problem with the body's immune system.


Normally, the immune system helps protect the body from harmful substances.  But in patients with an autoimmune disease, the immune system cannot tell the difference between harmful substances and healthy ones.  As a result, the immune system attacks otherwise healthy cells and tissue.
== [[Lupus nephritis classification|Classification]] ==


==Differentiating from other Diseases==
== [[Lupus nephritis pathophysiology|Pathophysiology]] ==
Diseases with similar symptoms are


* [[Chronic glomerulonephritis]]
== [[Lupus nephritis causes|Causes]] ==
* [[Polyarteritis nodosa]]
* [[Wegener granulomatosis ]]


==Natural History, Complications and Prognosis==
== [[Differentiating lupus nephritis from other diseases|Differentiating Lupus nephritis from other Diseases]] ==
===Natural History===
[[Lupus nephritis]] may damage different parts of the kidney.  Class I has normal histology and does not show any evidence of disease and class V shows an extensive disease.


===Complications===
== [[Lupus nephritis epidemiology and demographics|Epidemiology and Demographics]] ==
Possible complications include:
* Interstitial nephritis
* [[Nephrotic syndrome]]
* [[Membranous glomerulonephritis]]
* [[Kidney failure]] - acute and chronic
* [[End stage renal disease]]


===Prognosis===
== [[Lupus nephritis risk factors|Risk Factors]] ==
* Age onset of lupus nephritis: Young age onset carries worse prognosis.
==[[Lupus nephritis screening|Screening]]==
* Male gender have poorer outcomes than female.
* Black race have worse outcomes than other races.
* Prognosis depends on the specific form of lupus nephritis.  Patients may have flare-ups in between symptom free intervals.
* Although lupus nephritis may return in a transplanted kidney, it rarely leads to [[end-stage kidney disease]].


==Diagnosis==
== [[Lupus nephritis natural history, complications and prognosis|Natural History, Complications and Prognosis]] ==
===Symptoms===
Sufferers of lupus nephritis may or may not have symptoms of [[kidney disease]], but it can manifest itself through:
* [[Weight gain]]
* Darker foamy [[urine]]
* [[Edema|Swelling]] around the eyes, legs, ankles or fingers.


Furthermore, patients may suffer from other symptoms of lupus unrelated to kidney function.  Such symptoms can include
== Diagnosis ==
* [[Arthritis]] - joint pains
[[Diagnostic criteria]] | [[Lupus nephritis history and symptoms|History and Symptoms]] | [[Lupus nephritis physical examination|Physical Examination]] | [[Lupus nephritis laboratory findings|Laboratory Findings]] | [[Lupus nephritis chest x ray|Chest X Ray]] | [[Lupus nephritis CT|CT]] | [[Lupus nephritis MRI|MRI]] | [[Lupus nephritis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Lupus nephritis other imaging findings|Other Imaging Findings]] | [[Lupus nephritis other diagnostic studies|Other Diagnostic Studies]]
* [[Fevers]]
* Gastro-intenstinal disturbances
* [[Headaches]]
* [[Fatigue (physical)|Fatigue]]
* Swollen joints


===Physical Examination===
== Treatment ==
====Vitals====
* [[Elevated body temperature]]
* [[Hypertension|High blood pressure]]


====Eyes====
[[Lupus nephritis medical therapy|Medical Therapy]] | [[Lupus nephritis surgery|Surgery]] | [[Lupus nephritis primary prevention|Primary Prevention]] | [[Lupus nephritis secondary prevention|Secondary Prevention]] | [[Lupus nephritis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lupus nephritis future or investigational therapies|Future or Investigational Therapies]]
* Peri-orbital puffiness can be noticed in patients with advanced disease having [[renal failure]].


====Extremities====
==Case Studies==
* [[Edema|Swelling]] around the legs, ankles or fingers.
[[Lupus nephritis case study one|Case #1]]
* Swollen joints
 
===Laboratory Findings===
Tests that may be done include:
 
* [[ANA]] titer.
* [[BUN]] and [[creatinine]].
* [[Lupus test]].
* [[Urinalysis]].
* Urine [[immunoglobulin light chain]]
 
====Chest X-ray====
* Shows signs of fluid collection in the lungs in very severe cases.
 
====Ultrasound====
* [[Ultrasound]] scans of the kidneys
 
====Biopsy====
* A kidney biopsy is not used to diagnose lupus nephritis, but to determine what treatment is appropriate.
* Severity of the disease can be assessed based on the histology of the biopsy specimen.
 
==Treatment==
===Medical Therapy===
* Medicines which decrease swelling, lower blood pressure and decrease inflammation by suppressing the immune system.
* Patients may need to monitor intake of protein, sodium, and potassium.
* Patients with severe disease should restrict their sodium intake to 2 grams per day and limit fluid as well.
* Depending on the histology, renal function and degree of [[proteinuria]], patients may require steroid therapy or [[chemotherapy]] regimens such as cyclophosphamide, [[azathioprine]], mycophenolate mofetil or [[cyclosporine]].
* [[Dialysis]] to control symtopms of [[kidney failure]].  There are two types of dialysis, [[hemodialysis]] and [[peritoneal dialysis]].
 
The drug therapy for lupus nephritis depends on the severity of the disease.
* For mild disease, [[corticosteroid]]s are generally prescribed. More severe disease requires treatment with immunosuppressant agents.  The two most commonly used agents are [[mycophenolate mofetil]] and intravenous [[cyclophosphamide]].  One recent study compared these two drugs.<ref name="Ginzler">Ginzler EM, Dooley MA, Aranow C, Kim MY, et al. "Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis." New England Journal of Medicine. 353:21. 2219-2229. 24 November 2005.</ref>
* The authors showed that patients with Class III or IV disease are more likely to benefit from [[mycophenolate mofetil]] as compared to [[cyclophosphamide]].  As a result, mycophenolate mofetil is now considered to be the first-line therapy for this disease.
 
===Surgical Therapy===
* A kidney [[transplant]] may be recommended.  People with active lupus should not have a transplant because the condition can occur in the transplanted kidney.
 
==References==
{{Reflist|2}}
 
==External links==
*[http://www.lupusclinicalstudy.com/ Lupus Nephritis Clinical Research Study]
*[http://www.londonlupuscentre.co.uk/ London Lupus Centre - Treatment, Diagnosis, Research]
*[http://www.lupus.org/ Lupus Foundation of America, Inc.]
*[http://www.lupusresearchinstitute.org/ Lupus Research Institute]
*[http://www.lupusny.org/ S.L.E. Lupus Foundation]
*[http://www.lupusinternational.com/ Lupus International]


{{Nephrology}}
{{Nephrology}}

Latest revision as of 20:36, 19 July 2018

Lupus nephritis
Type IV lupus nephritis: The classic "flea-bitten" appearance of the cortical surface in the diffuse proliferative glomerulonephritides. (Courtesy of Ed Uthman, MD)]]

Lupus nephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lupus nephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lupus nephritis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lupus nephritis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lupus nephritis

CDC on Lupus nephritis

Lupus nephritis in the news

Blogs on Lupus nephritis

Directions to Hospitals Treating Lupus nephritis

Risk calculators and risk factors for Lupus nephritis

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2] Cafer Zorkun, M.D., Ph.D. [2]; Ujjwal Rastogi, MBBS [3]; Aida Javanbakht, M.D.Raviteja Guddeti, M.B.B.S. [4] 

Synonyms and keywords: Nephritis - lupus; lupus glomerular disease

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lupus nephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:Nephrology


Template:WikiDoc Sources